Bodo Grimbacher, Germany
Medical Center - University of Freiburg Institute for Immunodeficiency and Center for Chronic ImmunodeficiencyGrimbacher, Bodo
Prof. Dr. med. *23.01.1967, male
married, 4 children
Institute for Immunodeficiency
Center for Chronic Immunodeficiency
Medical Center - University of Freiburg
Breisacher Str. 115
D-79106 Freiburg
Phone: +49 (0)761 270-77732
E-mail: bodo.grimbacher@uniklinik-freiburg.de
Current position
W3 Professor
Scientific Director, Center for Chronic Immunodeficiency, University Medical Center Freiburg
Academic training
1988 – 1995 Medical studies in Aachen, Freiburg and Hamburg
Scientific qualifications
2006 Habilitation in Internal Medicine, University of Freiburg (Mentor: Prof. H. H. Peter)
1995 Dissertation in Medicine, University of Freiburg (Supervisor: Prof. H. Eibel)
Postgraduate Positions
since 2011 Scientific Director and consultant at the CCI, Medical Center - University of Freiburg
2006 - 2011 Consultant and Head of Marie-Curie Research Group, Dept. of Immunology, Royal Free Hospital & University College London, UK
2000 - 2006 Assistant lecturer and Emmy Noether-Fellow of the DFG, Division of Rheumatology and Clinical Immunology, Medical Center – University of Freiburg
1997 - 2000 Postdoctorate, NIH, National Human Genome Institute, Bethesda, MD, USA
1995 – 1997 Postdoctorate, Division of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg
Miscellaneous (Honors, Awards)
2009 Thieme Research Prize of the Leopoldina, Halle
2007 Rudolph-Schoen Prize, Hannover Medical School
2006 Marie-Curie Excellence Award of the European Commission for 4 years
2006 Georges Köhler Award 2006 of the German Immunology Society
2002 Admission to the Emmy-Noether program of the German Research Foundation
Presenter of 1 Presentation
Plenary Session
No Topic Needed
INCREASED RISK OF LYMPHOMA IN CTLA4 AND LRBA DEFICIENCY
Lecture Time
09:15 - 09:40
Presenter
Room
Bozar
Date
19.09.2019, Thursday
Session Time
08:50 - 10:30
Presentation Topic
No Topic Needed
Abstract
Abstract Body
This lecture will report on the malignancy risk in variuous immune dysregulation syndromes such as CTLA4 insufficiency, LRBA deficiency, and NFkB insufficiency. Case reports will illustrate the topic. Treatment options will be reviewed. A final quiz will test the knowledge of the audience.